- Echo will host a webcast and conference call on Tuesday, March 3, 2015 at 4:30 p.m. ET to introduce its new management team and to discuss its corporate strategy and short- and intermediate-term milestones. Participants can access the webcast at: Corporate Update Webcast or participants choosing to dial-in are encouraged to pre-register for the call at: Dial-In Pre-Registration to obtain a PIN and gain immediate access to the call. Participants unable to pre-register may still participate by dialing 1-855-327-6837 and asking the operator to join the "Echo Therapeutics Update Call"
- Following the ADA Scientific Sessions oral presentation on June 8, 2012, Echo hosted a panel discussion on hospital-based glucose control with Key Opinion Leaders (KOLs) in glycemic control. Anthony Furnary, M.D. (Starr-Wood Cardiac Group, Portland, OR), Jeffrey Joseph, D.O. (Thomas Jefferson University Hospital, Philadelphia, PA), Stanley Nasraway, M.D. (Tufts Surgical Center, Boston, MA), and Eileen Donnelly, R.N., B.S.N. (Thomas Jefferson University Hospital, Philadelphia, PA) discussed the need for continuous glucose monitoring in hospitals. Here is the link to the symposium video: Hospital-Based Glucose Control Symposium
- Listen to Robert Langer, David H. Koch Institute Professor at the Massachusetts Institute of Technology (MIT) and pioneer in transdermal drug delivery systems, discuss Echo's Prelude SkinPrep System and Symphony CGM System: Robert Langer interview